BioSpace News Archive

Predictive Oncology Inc. today announced that Raymond F. Vennare, Chief Executive Officer, will present at the upcoming Biotech Showcase, in San Francisco, CA, on January 9, 2024, at 4:00 p.m. PT.

XORTX Therapeutics Inc. welcomes Mr. Patrick Treanor to the Board of Directors and announces the resignation of Ian Klassen, both effective December 31, 2023.

Fortrea today announced that Chairman and Chief Executive Officer, Tom Pike and Chief Financial Officer, Jill McConnell will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10 at 3:00 pm PST.

Leap Therapeutics, Inc. today announced that enrollment has been completed in the randomized controlled Part C of the DisTinGuish study evaluating DKN-01.

MannKind Corporation announced that on December 27, 2023 it sold a 1% royalty in net sales of Tyvaso DPI® inhalation powder in exchange for up to $200 million, including the purchase price of $150 million and an additional potential milestone payment of up to $50 million.

Exact Sciences Corp. today announced that company management will participate in the following conference and invited investors to participate by webcast.

Sage Therapeutics, Inc. announced today that the Company will present at the 42 nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 4:30 p.m. PT in San Francisco, CA.

CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and organ manufacturing, today announced its initiation of a pre-clinical trial to evaluate commercial-size, 3D-bioprinted, regenerative breast implants.

Star Therapeutics today announced that Adam Rosenthal, Ph.D., CEO and Founder, will present a company overview at the 42nd annual J.P. Morgan Healthcare Conference on Thursday, January 11th at 10:30 a.m. PT.

Deciphera Pharmaceuticals, Inc. today announced that Steve Hoerter, President and Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 4:30 PM PT / 7:30 PM ET.